Chc Meditech Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 1.00 M
- Company Age 15 Year, 5 Days
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.01 M
- Revenue Growth 78.04%
- Profit Growth 4656.87%
- Ebitda 212.52%
- Net Worth 12.03%
- Total Assets -4.91%
About Chc Meditech
Chc Meditech Private Limited (CMPL) is a Private Limited Indian Non-Government Company incorporated in India on 08 February 2010 and has a history of 15 years. Its registered office is in Delhi, India.
The Company is engaged in the Information Technology Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹2.01 M.
The Key Managerial Personnel (KMP) at Chc Meditech Private Limited India are Senthil Kandeepan as CEO and Jayasri Kandeepan as Cfo. Chinnappa Kowsalya, Jayasri Kandeepan, and Senthil Kandeepan serve as directors at the Company.
Company Details
-
Location
Delhi, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U33110DL2010PTC198824
-
Company No.
198824
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
08 Feb 2010
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Chc Meditech?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jayasri Kandeepan
|
CFO | 28-Aug-2020 | Current |
|
Senthil Kandeepan
|
CEO | 08-Feb-2010 | Current |
Board Members (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Chinnappa Kowsalya
|
Director | 18-Dec-2018 | Current |
Financial Performance of Chc Meditech.
Chc Meditech Private Limited, for the financial year ended 2016, experienced significant growth in revenue, with a 78.04% increase. The company also saw a substantial improvement in profitability, with a 4656.87% increase in profit. The company's net worth Soared by an impressive increase of 12.03%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Chc Meditech?
In 2016, Chc Meditech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
-
Chc Homeicu Private LimitedJayasri Kandeepan and Senthil Kandeepan are mutual person
Charges (Loans)
₹2.01 M
₹0
Charges Breakdown by Lending Institutions
- Others : 0.20 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 05 Apr 2011 | Others | ₹2.01 M | Open |
How Many Employees Work at Chc Meditech?
Unlock and access historical data on people associated with Chc Meditech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Chc Meditech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Chc Meditech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
